07:00 , Sep 5, 2016 |  BC Week In Review  |  Financial News

ABLS II completes venture financing

Allied-Bristol Life Sciences II LLC , Boston, Mass.   Business: Autoimmune, Inflammation   Date completed: 2016-08-22   Type: Venture financing   Raised: $15 million   Investors: Allied Minds; Bristol-Myers Squibb Co.  ...
07:00 , Aug 22, 2016 |  BC Extra  |  Financial News

ABLS spinout raises $15M in series A round

Allied Minds plc (LSE:ALM) said fibrosis and autoimmune start-up ABLS II LLC raised $15 million in a series A round. ABLS II is among three companies spun out from joint venture Allied-Bristol Life Sciences LLC,...
07:00 , May 30, 2016 |  BC Week In Review  |  Company News

Bristol-Myers, Allied Minds deal

Allied-Bristol Life Sciences, a jointly owned company formed in 2014 by Bristol-Myers Squibb and Allied Minds, said its ABLS II LLC subsidiary completed its drug candidate feasibility program. The subsidiary will receive $15 million to...